4//SEC Filing
Karydas Daphne 4
Accession 0000899243-20-033748
CIK 0001664106other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:46 PM ET
Size
5.3 KB
Accession
0000899243-20-033748
Insider Transaction Report
Form 4
Karydas Daphne
Director
Transactions
- Award
Stock Option (right to buy)
2020-12-10+20,000→ 20,000 totalExercise: $7.36Exp: 2030-12-10→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable in equal installments on each of the first three anniversaries of the grant date, December 10, 2020.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001816952
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 4:46 PM ET
- Size
- 5.3 KB